Global stock market indices dropped on Monday, July 24, with U.S. stock indexes down slightly. Johnson & Johnson’s shares fell 1.5 percent after South Korea’s Samsung Bioepis said it started U.S sales of the company’s top-selling drug Remicade.
The Dow Jones Industrial Average was down 68.13 points, or 0.32 percent, to 21,511.94, the S&P 500 had lost 4.44 points, or 0.18 percent, to 2,468.1 and the Nasdaq Composite had dropped 1.70 points, or 0.03 percent, to 6,386.05. European shares were also down.
U.S. dollar jumped from its lowest level in more than a year and U.S. Treasury yields climbed on Monday as investors braced for news from this week’s U.S. central bank meeting and possible hints on when the next interest rate hike is coming.
Oil reversed earlier falls to advance after leading OPEC producer Saudi Arabia pledged to limit exports next month.
Brent September crude futures were up 44 cents on the day at $48.50 a barrel, while NYMEX crude for September delivery rose 39 cents to $46.16.
